• About us
• Contact

Advertisement

Organisation › Details

British Patient Capital Ltd. (BPC)

British Patient Capital is the trading name of British Patient Capital Limited, a subsidiary of British Business Bank plc. Its mission is to enable long-term investment in innovative firms led by ambitious entrepreneurs who want to build large scale businesses. British Patient Capital is a £2.5bn investment programme designed to support high growth potential innovative UK businesses in accessing the long-term financing they require to scale up. The existing Venture Capital Catalyst programme is a programme of British Business Investments Ltd. British Patient Capital Limited and British Business Investments Ltd are commercial subsidiaries of British Business Bank plc. British Business Bank plc and its principal operating subsidiaries are not banking institutions and do not operate as such. A complete legal structure chart for British Business Bank plc and its subsidiaries can be found on the British Business Bank plc website. *

 

	Start	2018-06-13 established
	Group	United Kingdom (GB) (govt)
	Industry	finance
	Industry 2	business development (state/region)
	Region	Sheffield, South Yorkshire
	Country	United Kingdom (GB)
	City	n. a.
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2024-10-09

Advertisement

More documents for United Kingdom (GB) (govt)

• [1] Revvity, Inc.. (11/20/24). "Press Release: Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK". Waltham, MA....
• [2] ERS Genomics Ltd.. (9/4/24). "Press Release: ERS Genomics and Medicines Discovery Catapult Sign CRISPR/Cas9 License Agreement". Dublin & Cheshire....
• [3] BoobyBiome Ltd.. (8/22/24). "Press Release: BoobyBiome Secures £1.6M Innovate UK Biomedical Catalyst Grant for Groundbreaking Synbiotic Research". London....
• [4] Fujifilm Diosynth Biotechnologies UK Ltd.. (8/20/24). "Press Release: Fujifilm Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility". Billingham....
• [5] Good Dog Food Ltd. (d/b/a Meatly). (7/10/24). "Press Release: World-First Regulatory Approval. Meatly Becomes First Ever European Company Authorised to Sell Cultivated Meat, Following UK Clearance for Its Cultivated Pet Food"....
• [6] Cellular Origins Ltd.. (5/29/24). "Press Release: Cellular Origins and Cell and Gene Therapy Catapult Collaborate to Demonstrate Universal Automation of CGT Manufacturing". Cambridge & Stevenage....
• [7] Cell and Gene Therapy Catapult, The. (5/15/24). "Press Release: UK and Swiss Consortium to Apply Innovative Technologies to Lower Cost of Manufacturing Cell and Gene Therapies". London & Zurich....
• [8] SolasCure Ltd.. (3/20/24). "Press Release: SolasCure Awarded £405K Innovate UK Biomedical Catalyst Grant to Advance Chronic Wound Care". Cambridge....
• [9] Earlybird VC Management GmbH & Co KG. (2/14/24). "Press Release: Earlybird Health Closes Fresh Fund of EUR 173m". Berlin & Cologne....
• [10] UK Government (Dept. for Science, Innovation and Technology). (12/5/23). "Press Release: Government Publishes £2 Billion Vision for Engineering Biology to Revolutionise Medicine, Food and Environmental Protection"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.